U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H27NO2.ClH
Molecular Weight 373.916
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMINEPTINE HYDROCHLORIDE

SMILES

Cl.OC(=O)CCCCCCNC1C2=CC=CC=C2CCC3=C1C=CC=C3

InChI

InChIKey=VDPUXONTAVMIKZ-UHFFFAOYSA-N
InChI=1S/C22H27NO2.ClH/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22;/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25);1H

HIDE SMILES / InChI
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C22H27NO2
Molecular Weight 337.4553
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Amineptine is a selective inhibitor of dopamine reuptake. The drug was developed in France and was marketed for the treatment of depressive disorders under the name Survector among the others. Amineptine was withdrawn from the French market in 1999 because of abuse and drug dependence and because of its hepatic (cholestatic injuries) and cutaneous (acne) adverse effects.

CNS Activity

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Withdrawn
Survector

Approved Use

Survector 100mg tablet is used in the treatment of depression.

Launch Date

1977
PubMed

PubMed

TitleDatePubMed
[The problem of side-effects: cardiotoxicity (author's transl)].
1981
[Hepatitis, cholestasis and amineptine (author's transl)].
1981 Dec 18-25
[Value of amineptin in the treatment of different depressive states. Apropos of 112 cases treated as part of a national multi-centric study].
1985 Jul-Aug
[Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance].
1990 Sep-Oct
[Amineptin dependence and iatrogenic acne. Review of the literature apropos of a case].
1991 Dec
[Acne induced by amineptin: adnexal toxiderma].
1996
Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.
1997 Sep
WHO Expert Committee on Drug Dependence. Thirty-second report.
2001
Acneiform eruption caused by amineptine. A case report and review of the literature.
2001 Jul
Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme.
2001 Mar
Dopaminergic augmentation of sleep deprivation effects in bipolar depression.
2001 Nov 30
Sex-dependent modulation of treatment response.
2004 Mar
Antidepressants for anorexia nervosa.
2006 Jan 25
[A case of tianeptine abuse].
2006 Spring
[Acne induced by amineptine].
2009 Jan-Feb
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
2009 Jun
A new strategy for antidepressant prescription.
2010
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.
2010 Dec
Molecular biology research in neuropsychiatry: India's contribution.
2010 Jan
Patents

Patents

US8158152
7

Sample Use Guides

In Vivo Use Guide
Sources: www.ncbi.nlm.nih.gov/pubmed/21584062
Patients receive 200 mg of amineptine (survector) daily, in two divided doses at 8 A.M. and 12 noon for 6 weeks.
Route of Administration: Oral
In Vitro Use Guide
Rat neurones were treated with 300 nM-30uM of amineptine. Amineptine (1-30uM) decreased spontaneous firing and slightly hyperpolarized the membrane potential. At 300 nM-30uM amineptine increased the amplitude and duration of responses to exogenously applied dopamine.
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:00:55 GMT 2023
Edited
by admin
on Fri Dec 15 17:00:55 GMT 2023
Record UNII
A5P604A12R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMINEPTINE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
HEPTANOIC ACID, 7-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)AMINO)-, HYDROCHLORIDE (1:1)
Common Name English
AMINEPTINE HYDROCHLORIDE [MART.]
Common Name English
7-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)AMINO)HEPTANOIC ACID MONOHYDROCHLORIDE
Systematic Name English
SURVECTOR
Brand Name English
S-1694
Code English
AMINEPTINE HCL
Common Name English
AMINEPTINE HYDROCHLORIDE [MI]
Common Name English
MANEON
Brand Name English
Amineptine hydrochloride [WHO-DD]
Common Name English
AMINEPTENE HYDROCHLORIDE
Common Name English
Code System Code Type Description
CHEBI
32499
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
ECHA (EC/EINECS)
250-107-3
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
DRUG BANK
DBSALT000803
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
EVMPD
SUB00447MIG
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
CAS
30272-08-3
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
FDA UNII
A5P604A12R
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
MERCK INDEX
m1673
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID20952633
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
SMS_ID
100000085152
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
PUBCHEM
34869
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
CHEBI
50003
Created by admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
PRIMARY
Related Record Type Details
Structure of AMINEPTINE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of AMINEPTINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966